Register entry

Sucampo Pharma Americas, LLC

Data as of · How to read this entry

Registered sites
2
Active NDC listings
0
Live patents
6
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture1Finished drug manufacture1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
SUCAMPO PHARMA LIMITED LIABILITY COMPANYRegistrant: Sucampo Pharma Americas, LLC6-7-6, MINATOJIMAMINAMIMACHI, CHUO-KU KOBEHAIBURIDDOBIJINESUSENTA, KOBE, Hyogo 650-0047, Japan (JPN)Analytical testing3009036781691314841
SUCAMPO PHARMA LIMITED LIABILITY COMPANYRegistrant: Sucampo Pharma Americas, LLC4-1, TECHNOPARK, SANDA, Hyogo 669-1339, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3004520523718192151
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
8338639AMITIZAlubiprostoneproductJan 2027
8779187AMITIZAlubiprostoneproductJan 2027
8026393AMITIZAlubiprostoneproductOct 2027
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Sucampo Pharma Americas, LLC FDA approved?
Sucampo Pharma Americas, LLC holds 2 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Sucampo Pharma Americas, LLC's drugs manufactured?
The FDA register lists KOBE; SANDA. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.